Summary for Patients: Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide

Authors:

Published: 2025-04-04

DOI: 10.7326/annals-24-03849-ps

Source: Full article

---

Abstract

No abstract found.